Topiramate
Product Images NDC 12634-453

3 FDA label images from Apotheca Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 12634-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (453 71)

Label (453 71)
Topiramate 50 mg packaging label from Apotheca Inc. The label indicates a bottle of 30 tablets with NDC 12634-453-71. It includes dosing instructions to take tablets by mouth as directed by a physician, storage conditions, and cautions about alcohol and side effects. The label also notes the product is Rx only and packaged with a child-resistant closure.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of the active ingredient Topiramate, showing its distinct cyclic sulfate and multiple methyl groups in a stereochemically detailed molecular representation.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A Kaplan-Meier curve graph showing cumulative rates for time to first seizure in patients taking Topiramate. Two dosage groups are compared: 50 mg/day (N=234) and 400 mg/day (N=236) over approximately 500 days. The y-axis represents the cumulative rates for time to first seizure, while the x-axis shows time in days. The graph includes a statistical p-value of 0.0002 indicating a significant difference between groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.